🔎 Trials Near Me

Akèy › Twoub depresif majè › Texas › Dallas

Etid klinik pou Twoub depresif majè nan Dallas, TX

9 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Future Search Trials of Dallas, Dallas
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 2
  • FutureSearch Trials of Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Ap rekriteFaz 2
  • Seaport Investigator Site, Dallas
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • University of Texas Southwestern Medical Center at Dallas, Dallas
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Dallas
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Ap rekriteEtid obsèvasyon
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 40 · Tout sèks · Mizajou Mar 10, 2026 · NCT06740383

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Dallas
  • Clinical Research Site, Dallas
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.